Candidate tumor-specific CD8 <sup>+</sup> T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis-Reference-Cited by-同舟云学术

Candidate tumor-specific CD8 ⁺ T cell subsets identified in the malignant pleural effusion of advanced lung cancer patients by single-cell analysis

Published:2024-06-28 Issue:1 Volume:13 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Sugita Yusuke¹²,Muraoka Daisuke¹,Demachi-Okamura Ayako¹,Komuro Hiroyasu¹,Masago Katsuhiro³,Sasaki Eiichi³,Fukushima Yasunori¹,Matsui Takuya¹,Shinohara Shuichi¹,Takahashi Yusuke¹,Nishida Reina¹,Takashima Chieko¹,Yamaguchi Teppei⁴,Horio Yoshitsugu⁴,Hashimoto Kana⁵,Tanaka Ichidai⁶,Hamana Hiroshi⁷,Kishi Hiroyuki⁷,Miura Daiki⁸,Tanaka Yuki⁸,Onoue Kousuke⁸,Onoguchi Kazuhide⁸,Yamashita Yoshiko⁸,Stratford Richard⁹,Clancy Trevor⁹,Yamaguchi Rui¹⁰¹¹,Kuroda Hiroaki¹²,Ishibashi Hironori²,Okubo Kenichi²,Matsushita Hirokazu¹¹³^ORCID

Affiliation:

1. Division of Translational Oncoimmunology, Aichi Cancer Center Research Institute, Nagoya, Japan

2. Department of Thoracic Surgery, Tokyo Medical and Dental University, Tokyo, Japan

3. Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan

4. Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan

5. Department of Respiratory Internal Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan

6. Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan

7. Department of Immunology, Faculty of Medicine, Academic Assembly, University of Toyama, Toyama, Japan

8. AI Drug Development Division, NEC Corporation, Tokyo, Japan

9. NEC OncoImmunity AS, Oslo Cancer Cluster, Oslo, Norway

10. Division of Cancer System Biology, Aichi Cancer Center Research Institute, Nagoya, Japan

11. Division of Cancer Informatics, Nagoya University Graduate School of Medicine, Nagoya, Japan

12. Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan

13. Division of Cancer Immunogenomics, Nagoya University Graduate School of Medicine, Nagoya, Japan

Funder

Aichi Cancer Center Joint Research Project on Priority Areas

Japan Society for the Promotion of Science

Japanese Respiratory Foundation

Takeda Science Foundation

Uehara Memorial Foundation

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2024.2371556

Reference34 articles.

1. Global Epidemiology of Lung Cancer

2. Lung cancer

3. Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes

4. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

5. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer